ClinicalTrials.Veeva

Menu
S

Solace Clinical Research | San Juan, Puerto Rico

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Sugar
Progestin
Elismetrep
Metformin
K-304
Cadisegliatin

Parent organization

This site is a part of Solace Clinical Research

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

5 of 6 total trials

A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine

This is a long-term safety study to evaluate the safety and tolerability of intermittent use of elismetrep in the acute treatment of migraine attacks.

Enrolling
Acute Migraine
Drug: Elismetrep
New

This study is being done to look at how well zenagamtide lowers blood sugar levels and body weight in people with type 2 diabetes when compared to pl...

Not yet enrolling
Diabetes Mellitus, Type 2
Drug: Placebo
Drug: Zenagamtide

This is a double-blind, randomized, multicenter, outpatient evaluation of the efficacy, safety, and tolerability of elismetrep, as compared with plac...

Enrolling
Migraine
Drug: Placebo
Drug: Elismetrep
New

The purpose of this clinical study is to find out if zenagamtide is safe and effective for treating people who have type 2 diabetes. There are 2 stud...

Not yet enrolling
Type 2 Diabetes
Drug: Zenagamtide
Drug: Placebo

This is a Phase 3 trial of cadisegliatin as adjunctive therapy to insulin in participants with Type 1 Diabetes Mellitus.

Active, not recruiting
Diabetes Mellitus, Type 1
Drug: Cadisegliatin 800 mg QD
Drug: Placebo

Trial sponsors

Novo Nordisk logo
T
Bayer logo
vTv Therapeutics logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems